GPCR Structure Therapeutics Inc

Price (delayed)

$39.25

Market cap

$2.79B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.64

Enterprise value

$2.48B

?
Relative Growth: Rel. Growth: 2
Relative Strength: Rel. Strength: 70
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 10

We are a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Our differentiated ...

Highlights
GPCR's debt is down by 24% YoY and by 11% QoQ
GPCR's quick ratio is up by 12% year-on-year and by 4.7% since the previous quarter
The equity has surged by 75% year-on-year but it has declined by 4.6% since the previous quarter
The net income has contracted by 21% from the previous quarter and by 19% YoY
GPCR's EPS is down by 10% QoQ

Key stats

What are the main financial stats of GPCR

GPCR stock price

How has the Structure Therapeutics stock price performed over time
Intraday
4.67%
1 week
-2.29%
1 month
-8.81%
1 year
78.41%
YTD
-43.57%
QTD
-18.57%

Financial performance

How have Structure Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$209.63M
Net income
-$170.34M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 21% from the previous quarter and by 19% YoY
GPCR's operating income is down by 19% from the previous quarter and by 15% YoY

Price vs fundamentals

How does GPCR's price correlate with its fundamentals

Growth

What is Structure Therapeutics's growth rate over time

Valuation

What is Structure Therapeutics stock price valuation
P/E
N/A
P/B
1.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GPCR's EPS is down by 10% QoQ
The equity has surged by 75% year-on-year but it has declined by 4.6% since the previous quarter
GPCR's P/B is 17% less than its last 4 quarters average of 2.2

Efficiency

How efficient is Structure Therapeutics business performance
The ROA has increased by 8% year-on-year but it has declined by 4.3% since the previous quarter
GPCR's return on equity is up by 7% year-on-year but it is down by 4.1% since the previous quarter
GPCR's ROIC is down by 3.4% from the previous quarter

Dividends

What is GPCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GPCR.

Financial health

How did Structure Therapeutics financials performed over time
Structure Therapeutics's total assets has surged by 74% YoY but it has decreased by 4.8% QoQ
Structure Therapeutics's total liabilities has increased by 46% YoY but it has decreased by 10% from the previous quarter
GPCR's debt is 100% lower than its equity
The debt to equity has dropped by 100% year-on-year
The equity has surged by 75% year-on-year but it has declined by 4.6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.